Financial results - UROPROMED SRL

Financial Summary - Uropromed Srl
Unique identification code: 23613152
Registration number: J01/441/2008
Nace: 8622
Sales - Ron
29.298
Net Profit - Ron
21.896
Employee
1
The most important financial indicators for the company Uropromed Srl - Unique Identification Number 23613152: sales in 2023 was 29.298 euro, registering a net profit of 21.896 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Uropromed Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 34.333 41.782 46.263 55.809 71.827 85.314 96.943 136.860 69.422 29.298
Total Income - EUR 34.333 41.782 46.263 61.488 202.954 85.314 98.431 136.860 69.422 29.447
Total Expenses - EUR 8.901 12.386 14.322 19.818 148.512 11.861 8.122 8.051 4.440 7.257
Gross Profit/Loss - EUR 25.432 29.395 31.942 41.670 54.442 73.454 90.309 128.809 64.982 22.191
Net Profit/Loss - EUR 24.403 28.142 30.788 41.055 52.413 72.600 89.391 127.440 64.288 21.896
Employees 2 2 3 2 3 3 4 4 4 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -57.7%, from 69.422 euro in the year 2022, to 29.298 euro in 2023. The Net Profit decreased by -42.196 euro, from 64.288 euro in 2022, to 21.896 in the last year.

Check the financial reports for the company - Uropromed Srl

Rating financiar

Financial Rating -
Uropromed Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Uropromed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Uropromed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Uropromed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Uropromed Srl - CUI 23613152

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 14.820 27.269 21.166 142.698 41.211 37.253 39.776 38.894 39.014 247.945
Current Assets 24.928 38.286 29.552 21.661 61.982 80.067 87.653 193.083 67.471 5.471
Inventories 0 0 0 0 0 0 0 10.760 0 0
Receivables 0 1.060 956 181 0 39.162 21.976 4.125 61.939 1.345
Cash 24.928 37.226 28.596 21.480 61.982 40.905 65.677 178.197 5.532 4.126
Shareholders Funds 36.984 63.184 47.011 74.136 52.456 72.769 89.556 191.561 64.450 26.199
Social Capital 45 45 45 44 43 169 165 162 162 162
Debts 2.764 2.371 3.707 90.223 50.737 44.551 37.873 40.416 42.036 46.090
Income in Advance 0 0 0 0 0 0 0 0 0 194.125
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 5.471 euro in 2023 which includes Inventories of 0 euro, Receivables of 1.345 euro and cash availability of 4.126 euro.
The company's Equity was valued at 26.199 euro, while total Liabilities amounted to 46.090 euro. Equity decreased by -38.055 euro, from 64.450 euro in 2022, to 26.199 in 2023. The Debt Ratio was 17.3% in the year 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Uropromed Srl

Comments - Uropromed Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.